UnknownPhase 4

Topical Bromfenac for Intraoperative Miosis and Pain Reduction

Mexico60 participantsStarted 2018-03-01

Plain-language summary

To evaluate the effect of bromfenac ophthalmic solution 0.09% for reduction of intraoperative miosis and pain in patient who have undergone femtosecond laser-assisted cataract surgery.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Male and female * Subjects 18 years or older * Patients scheduled for unilateral femtosecond laser-assisted cataract surgery cataract surgery with posterior chamber (PC) IOL implantation. Exclusion Criteria: * Presence of corneal abnormalities * History of intraocular surgery * History of ocular or systematic diseases (glaucoma, diabetes, uveitis * Regular, systemic use of steroid or NSAIDs during the previous 3 months

What they're measuring

intraoperative miosis

Timeframe: 2 days

Trial details

NCT IDNCT03831984

SponsorHospital de La Luz

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2018-11-30

View on ClinicalTrials.gov More Cataract trials